Hormone replacement influences homocysteine levels in the methionine-loading test: A randomized placebo controlled trial in postmenopausal women

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 117, Issue 1, 2004, Pages 55-59

  Smolders, R G V ^a   De Meer, K ^a   Kenemans, P ^a   Teerlink, T ^a   Jakobs, C ^a   Van Der Mooren, M J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Homocysteine; Methionine loading test; Oestrogen; Placebo; Progestogen; Randomized

Indexed keywords

CYANOCOBALAMIN; DYDROGESTERONE; DYDROGESTERONE PLUS ESTRADIOL; ESTRADIOL; FOLIC ACID; HOMOCYSTEINE; METHIONINE; PLACEBO; PYRIDOXINE;

ADULT; AGED; AMINO ACID METABOLISM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPOTHESIS; LOADING TEST; MODULATION; NORMAL HUMAN; OBSERVATION; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 5044239776     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2003.10.033     Document Type: Article

References (20)

1. Boushey C.J., Beresford S.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 274:1995;1049-1057
2. Refsum H., Ueland P.M., Nygard O., Vollset S.E. Homocysteine and cardiovascular disease. Annu. Rev. Med. 49:1998;31-62
3. Peterson J.C., Spence J.D. Vitamins and progression of atherosclerosis in hyper-homocyst(e)inaemia. Lancet. 351:1998;263
4. 6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Lancet. 355:2000;517-522
5. Schnyder G., Roffi M., Pin R., Flammer Y., Lange H., Eberl F.R., et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N. Engl. J. Med. 345:2001;1593-1600
6. Van der Mooren M.J., Wouters M.G., Blom H.J., Schellekens L.A., Eskes T.K., Rolland R. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women. Eur. J. Clin. Invest. 24:1994;733-736
7. Mijatovic V., Kenemans P., Netelenbos C., Jakobs C., Popp-Snijders C., Peters-Muller E.R., et al. Postmenopausal oral 17beta-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels. Fert. Steril. 69:1998;876-882
8. Mijatovic V., Kenemans P., Jakobs C., van Baal W.M., Peters-Muller E.R., van der Mooren M.J. A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women. Obstet. Gynecol. 91:1998;432-436
9. Barnabei V.M., Phillips T.M., Hsia J. Plasma homocysteine in women taking hormone replacement therapy: the postmenopausal estrogen/progestin interventions (PEPI) trial. J. Womens Health Gend. Based Med. 8:1999;1167-1172
10. Van Baal W.M., Smolders R.G.V., van der Mooren M.J., Teerlink T., Kenemans P. Hormone replacement therapy and plasma homocysteine levels. Obstet. Gynecol. 94:1999;485-491
11. Hak A.E., Bak A.A., Lindemans J., Planellas J., Coelingh Bennink H.J., Hofman A., et al. The effect of hormone replacement therapy on serum homocysteine levels in perimenopausal women: a randomized controlled trial. Atherosclerosis. 158:2001;437-443
12. Ventura P., Cagnacci A., Malmusi S., Panini R., Baldassari F., Arangino S., et al. Continuous combined hormone replacement therapy with oral 17beta-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women. Menopause. 8:2001;252-258
13. Smolders R.G.V., Vogelvang T.E., Mijatovic V., van Baal W.M., Neele S.J.M., Nefelenbos J.C., et al. A 2-year, randomized, comparative, placebo-controlled study on the effects of raloxifene on lipoprotein(a) and homocysteine. Maturitas. 41:2002;105-114
14. Finkelstein J.D. The metabolism of homocysteine: pathways and regulation. Eur. J. Pediatr. 157(Suppl. 2):1998;S40-4
15. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10:1995;111-113
16. De Bree A., Verschuren W.M., Blom H.J., Kromhout D. Association between B vitamin intake and plasma homocysteine concentration in the general Dutch population aged 20-65 years. Am. J. Clin. Nutr. 73:2001;1027-1033
17. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 280:1998;605-613
18. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321-33.
19. Steegers-Theunissen R.P., van Rossum J.M., Steegers E.A., Thomas C.M., Eskes T.K. Sub-50 oral contraceptives affect folate kinetics. Gynecol. Obstet. Invest. 36:1993;230-233
20. Berger P.B., Herrmann R.R., Dumesic D.A. The effect of estrogen replacement therapy on total plasma homocysteine in healthy postmenopausal women. Mayo. Clin. Proc. 75:2000;18-23